Generation and characterization of nucleic acid aptamers targeting the capsid P domain of a human norovirus GII.4 strain.

J Biotechnol

Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, 315 Schaub Hall, 400 Dan Allen Drive, Raleigh, NC 27695, USA.

Published: September 2015

Human noroviruses (NoV) are the leading cause of acute viral gastroenteritis worldwide. Significant antigenic diversity of NoV strains has limited the availability of broadly reactive ligands for design of detection assays. The purpose of this work was to produce and characterize single stranded (ss)DNA aptamers with binding specificity to human NoV using an easily produced NoV target-the P domain protein. Aptamer selection was done using SELEX (Systematic Evolution of Ligands by EXponential enrichment) directed against an Escherichia coli-expressed and purified epidemic NoV GII.4 strain P domain. Two of six unique aptamers (designated M1 and M6-2) were chosen for characterization. Inclusivity testing using an enzyme-linked aptamer sorbent assay (ELASA) against a panel of 14 virus-like particles (VLPs) showed these aptamers had broad reactivity and exhibited strong binding to GI.7, GII.2, two GII.4 strains, and GII.7 VLPs. Aptamer M6-2 exhibited at least low to moderate binding to all VLPs tested. Aptamers significantly (p<0.05) bound virus in partially purified GII.4 New Orleans outbreak stool specimens as demonstrated by ELASA and aptamer magnetic capture (AMC) followed by RT-qPCR. This is the first demonstration of human NoV P domain protein as a functional target for the selection of nucleic acid aptamers that specifically bind and broadly recognize diverse human NoV strains.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiotec.2015.06.389DOI Listing

Publication Analysis

Top Keywords

gii4 strain
8
aptamers
5
nov
5
generation characterization
4
characterization nucleic
4
nucleic acid
4
acid aptamers
4
aptamers targeting
4
targeting capsid
4
capsid domain
4

Similar Publications

Prevalence of Human Norovirus GII.4 Sydney 2012 [P31] between 2019 and 2021 among Young Children from Rural Communities in South Africa.

Viruses

August 2023

Department of Biochemistry and Microbiology, Faculty of Science, Engineering and Agriculture, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa.

Acute gastroenteritis (AGE) accounts for considerable morbidity and mortality in the paediatric population worldwide, especially in low-income countries. Human norovirus (HNoV), particularly GII.4 strains, are important agents of AGE.

View Article and Find Full Text PDF

Background: Globally, Norovirus (NoV) is considered the most common cause of diarrheal episodes across all age groups. Despite its wide genetic diversity, the GII.4 strain is the most predominant and has been associated with epidemics worldwide.

View Article and Find Full Text PDF

Noroviruses are endemic in the human population, and are recognised as a leading cause of acute gastroenteritis worldwide. Although they are a highly diverse group of viruses, genogroup-II genotype-4 (GII-4) noroviruses are the most frequently identified strains worldwide. The predominance of GII-4 norovirus strains is driven by the periodic emergence of antigenic variants capable of evading herd protection.

View Article and Find Full Text PDF

Background: The global emergence of norovirus (NoV) GII.4 variants has raised public concerns in the world including South Korea since 1996.

Objective: We analyzed seasonality and genotypic pattern for sporadic cases by norovirus GII-4 variants.

View Article and Find Full Text PDF
Article Synopsis
  • Norovirus is a leading cause of acute gastroenteritis in children, and the study focused on understanding how IgG antibodies may protect against it.
  • Researchers examined serum samples from children infected with various norovirus strains to measure specific IgG levels and their blocking activity against these viruses.
  • Findings showed that children infected with a specific variant (GII-4 NO) had low antibody levels before infection but developed a stronger antibody response afterward, highlighting the protection is strain-specific.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!